-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Upgrades Gossamer Bio to Outperform, Maintains Price Target to $1

Benzinga·07/28/2026 10:50:34
Listen to the news
Leerink Partners analyst Joseph Schwartz upgrades Gossamer Bio (NASDAQ:GOSS) from Market Perform to Outperform and maintains the price target from $1 to $1.